PKTX.OTC.PinkProtokinetix, INC

Form 4: ProtoKinetix CEO Clarence Smith Acquires 2 Million Shares in Private Placement

Sentiment:

SEC Form 4 Filing


Clarence Smith, President and CEO of ProtoKinetix, Inc., reports the acquisition of 2,000,000 shares of common stock through a private placement.

Capital raiseClarence Smith acquired 2,000,000 shares of ProtoKinetix common stock through a private placement at a price of $0.01 per share.

Summary

  • Clarence Edward Smith, the President and CEO of ProtoKinetix, Inc. (PKTX), filed a Form 4 detailing changes in beneficial ownership.
  • On September 26, 2024, Smith acquired 2,000,000 shares of ProtoKinetix common stock through a private placement at a price of $0.01 per share.
  • Following the transaction, Smith directly owns 70,214,444 shares of common stock.
  • Smith also indirectly owns 13,572,649 shares through the Clarence E. Smith Trusts and 1,850,000 shares through his retirement account.
  • Smith holds options to purchase 32,350,000 shares of common stock at an exercise price of $0.028, exercisable until December 6, 2028.

Sentiment

Score: 6

Explanation: The CEO's purchase is a positive signal, but the document is simply a regulatory filing, so the sentiment is neutral to slightly positive.

Positives

  • The CEO's purchase of 2,000,000 shares could be interpreted as a sign of confidence in the company's future prospects.

Industry Context

Insider trading activity is always closely watched by investors as it can provide signals about management's view of the company's prospects. A purchase by the CEO is generally seen as a positive sign.

Stakeholder Impact

  • The CEO's increased stake could reassure shareholders.
  • The private placement may dilute existing shareholders depending on the overall size of the placement.

Key Dates

DateDescription
09/26/2024Date of the transaction: Clarence Smith acquired 2,000,000 shares of common stock.
09/27/2024Date of signature on the Form 4 filing.
12/06/2028Expiration date for stock options held by Clarence Smith.

Keywords

ProtoKinetix, Clarence Smith, insider trading, beneficial ownership, Form 4, private placement, PKTX, stock options

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.